省药监局出台90项举措 清单化推动我省药品医疗器械监管改革任务落地见效

Core Viewpoint - The Anhui Provincial Drug Administration has issued a detailed implementation list for the "Several Measures to Deepen Drug and Medical Device Regulatory Reform and Promote High-Quality Development of the Pharmaceutical Industry" to ensure effective execution of reform tasks [1] Group 1: Reform Measures - The implementation list focuses on 18 specific reform initiatives aimed at enhancing drug and medical device regulation, including strengthening research and development tracking services, supporting the market entry of new traditional Chinese medicines, and improving review and approval capabilities [1] - A total of 90 actionable tasks have been outlined to ensure the effective implementation of these reforms, with clear work objectives, responsible departments, and completion timelines established [1] Group 2: Coordination and Collaboration - The Provincial Drug Administration will integrate reform measures involving other departments into the 2026 provincial drug safety work priorities to ensure coordinated deployment and collaborative advancement [1] - The goal is to ensure comprehensive implementation of reform initiatives, fostering synergy to promote high-quality development of the pharmaceutical industry in the province [1]